EBSTEIN-BARR VIRUS ANTIBODIES TITER BEFORE AND AFTER RADIOTHERAPY IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA, CANCER INSTITUTE, IMAM KHOMEINI HOSPITAL, 2003 – 2004

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

AMOUZGAR HASHEMI F.; ESMATI E.; SAJADI M.; RAZI F.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Tehran University Medical Journal Year:2006 | Volume:64 | Issue:5 Page(s): 96-101

Download Full-Text

Persian Verion

View:

867

Download:

Cites:

Information Journal Paper

Title

EBSTEIN-BARR VIRUS ANTIBODIES TITER BEFORE AND AFTER RADIOTHERAPY IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA, CANCER INSTITUTE, IMAM KHOMEINI HOSPITAL, 2003 – 2004

Author(s)

AMOUZGAR HASHEMI F. | ESMATI E. | SAJADI M. | RAZI F. | Issue Writer Certificate

Keywords

RADIOTHERAPYQ3

NASOPHARYNGEAL CARCINOMAQ3

EPSTEIN BARR VIRUSQ3

Abstract

Background: High titer of IgA and IgG are found in the presence of EBV genome in epithelial cells of NASOPHARYNGEAL CARCINOMA. In this survey we evaluated the accuracy of EBV antibodies titers in screening and follow up the patients.Methods: Thirty NASOPHARYNGEAL CARCINOMA patients were followed from 2003 to 2004.Serum EBV antibody levels were measured before and after (3 months) RADIOTHERAPY or combined RADIOTHERAPY and chemotherapy.Results: More than 77% of patients were seropositive before treatment. The antibodies decreased significantly, 3 months after treatment (p<0.05).Conclusion: This investigation shows the efficiency of serologic methods for screening of high risk people and follow up of patients after treatment, but more complementary studies is needed.

Cites

No record.

References

No record.

Cite

APA: Copy

AMOUZGAR HASHEMI, F., ESMATI, E., SAJADI, M., & RAZI, F.. (2006). EBSTEIN-BARR VIRUS ANTIBODIES TITER BEFORE AND AFTER RADIOTHERAPY IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA, CANCER INSTITUTE, IMAM KHOMEINI HOSPITAL, 2003 – 2004. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), 64(5), 96-101. SID. https://sid.ir/paper/39520/en

Vancouver: Copy

AMOUZGAR HASHEMI F., ESMATI E., SAJADI M., RAZI F.. EBSTEIN-BARR VIRUS ANTIBODIES TITER BEFORE AND AFTER RADIOTHERAPY IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA, CANCER INSTITUTE, IMAM KHOMEINI HOSPITAL, 2003 – 2004. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ)[Internet]. 2006;64(5):96-101. Available from: https://sid.ir/paper/39520/en

IEEE: Copy

F. AMOUZGAR HASHEMI, E. ESMATI, M. SAJADI, and F. RAZI, “EBSTEIN-BARR VIRUS ANTIBODIES TITER BEFORE AND AFTER RADIOTHERAPY IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA, CANCER INSTITUTE, IMAM KHOMEINI HOSPITAL, 2003 – 2004,” TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), vol. 64, no. 5, pp. 96–101, 2006, [Online]. Available: https://sid.ir/paper/39520/en

Related Journal Papers